Within-Class Differences in Cancer Risk for Sulfonylurea Treatments in Patients With Type 2 Diabetes (ZODIAC-55) – A Study Protocol

BMC Cancer - United Kingdom
doi 10.1186/s12885-017-3433-z

Related search